The BPH treatment market and the stone management device market accounted for the majority of the total market value in 2019. The growth in these two segments is driven by the stable demand for related procedures, the growing prevalence of prostatic and kidney diseases and the premium prices for lasers and lithotripters.

Abstract
The full report suite on the Australian market for the urological devices includes urinary incontinence devices, pelvic organ prolapse treatment, stone management devices, benign prostate hyperplasia (BPH) treatment devices and erectile dysfunction devices.